This guideline provides expert consensus and recommendations for optimal rate control management tailored to Korean patients with atrial fibrillation.
Endorses lenient rate control for Korean AF patients; extends international trial evidence with localized expert consensus.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2018) conducted a review in Atrial Fibrillation. Rate control therapy (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin) was evaluated. The 2018 Korean Heart Rhythm Society guidelines recommend beta-blockers, non-dihydropyridine calcium channel blockers, or digoxin for rate control in atrial fibrillation, targeting a resting heart rate of <110 bpm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: